Shelter Pharma Limited launched FOLIMAN Folic Acid Tablets, a Vitamin B-9 supplement, on May 11, 2026.
The product launch is part of the company's strategy to expand its healthcare and nutraceutical product portfolio.
The product is initially targeting the international market, with potential domestic market introduction in the future.
The launch aims to strengthen the company's market presence and support long-term business growth in the healthcare segment.